{
    "title": "108_s2464",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Internet Pharmacy Consumer \nProtection Act'' or the ``Ryan Haight Act''.\n\nSEC. 2. INTERNET SALES OF PRESCRIPTION DRUGS.\n\n    (a) In General.--Chapter 5 of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by inserting after section 503A \nthe following:\n\n``SEC. 503B. INTERNET SALES OF PRESCRIPTION DRUGS.\n\n    ``(a) Requirements Regarding Information on Internet Site.--\n            ``(1) In general.--A person may not dispense a prescription \n        drug pursuant to a sale of the drug by such person if--\n                    ``(A) the purchaser of the drug submitted the \n                purchase order for the drug, or conducted any other \n                part of the sales transaction for the drug, through an \n                Internet site; and\n                    ``(B) such site, or any other Internet site used by \n                such person for purposes of sales of a prescription \n                drug, fails to meet each of the requirements specified \n                in paragraph (2) (other than a site or pages on a site \n                that are not intended to be accessed by purchasers or \n                prospective purchasers or that provide an Internet \n                information location tool within the meaning of section \n                231(e)(5) of the Communications Act of 1934 (47 U.S.C. \n                231(e)(5)).\n            ``(2) Requirements.--With respect to an Internet site, the \n        requirements referred to in subparagraph (B) of paragraph (1) \n        for a person to whom such paragraph applies are as follows:\n                    ``(A) Each page of the site shall include either \n                the following information or a link to a page that \n                provides the following information:\n                            ``(i) The name of such person; the address \n                        of the principal place of business of the \n                        person with respect to sales of prescription \n                        drugs through the Internet; and the telephone \n                        number for such place of business.\n                            ``(ii) Each State in which the person is \n                        authorized by law to dispense prescription \n                        drugs.\n                            ``(iii) The name of each individual who \n                        serves as a pharmacist for purposes of the \n                        site; and each State in which the individual is \n                        authorized by law to dispense prescription \n                        drugs.\n                            ``(iv) If the person provides for medical \n                        consultations through the site for purposes of \n                        providing prescriptions, the name of each \n                        individual who provides such consultations; \n                        each State in which the individual is licensed \n                        or otherwise authorized by law to provide such \n                        consultations or practice medicine; and the \n                        type or types of health professions for which \n                        the individual holds such licenses or other \n                        authorizations.\n                    ``(B) A link to which paragraph (1) applies shall \n                be displayed in a clear and prominent place and manner, \n                and shall include in the caption for the link the words \n                `licensing and contact information'.\n    ``(b) Internet Sales Without Appropriate Medical Relationships.--\n            ``(1) In general.--A person may not dispense a prescription \n        drug, or sell such a drug, if--\n                    ``(A) for purposes of such dispensing or sale, the \n                purchaser communicated with the person through the \n                Internet;\n                    ``(B) the patient for whom the drug was dispensed \n                or purchased did not, when such communications began, \n                have a prescription for the drug that is valid in the \n                United States;\n                    ``(C) pursuant to such communications, the person \n                provided for the involvement of a practitioner, or an \n                individual represented by the person as a practitioner, \n                and the practitioner or such individual issued a \n                prescription for the drug that was purchased;\n                    ``(D) the person knew, or had reason to know, that \n                the practitioner or the individual referred to in \n                subparagraph (C) did not, when issuing the \n                prescription, have a qualifying medical relationship \n                with the patient; and\n                    ``(E) the person received payment for the \n                dispensing or sale of the drug.\n        For purposes of subparagraph (E), payment is received if money \n        or other valuable consideration is received.\n            ``(2) Qualifying medical relationship.--\n                    ``(A) In general.--With respect to issuing a \n                prescription for a drug for a patient, a practitioner \n                has a qualifying medical relationship with the patient \n                for purposes of this section if at least 1 in-person \n                medical evaluation of the patient has been conducted by \n                the practitioner.\n                    ``(B) In-person medical evaluation.--A medical \n                evaluation by a practitioner is an in-person medical \n                evaluation for purposes of this section if the \n                practitioner is in the physical presence of the patient \n                as part of conducting the evaluation, without regard to \n                whether portions of the evaluation are conducted by \n                other health professionals.\n            ``(3) Rules of construction.--\n                    ``(A) Individuals represented as practitioners.--A \n                person who is not a practitioner (as defined in \n                subsection (e)(1)) lacks legal capacity under this \n                section to have a qualifying medical relationship with \n                any patient.\n                    ``(B) Applicability of requirements.--Paragraph (2) \n                may not be construed as having any applicability beyond \n                this section, and does not affect any State law, or \n                interpretation of State law, concerning the practice of \n                medicine.\n                    ``(C) Standard practice of pharmacy.--Paragraph (1) \n                may not be construed as prohibiting any conduct that is \n                a standard practice in the practice of pharmacy.\n    ``(c) Actions by States.--\n            ``(1) In general.--Whenever an attorney general of any \n        State has reason to believe that the interests of the residents \n        of that State have been or are being threatened or adversely \n        affected because any person has engaged or is engaging in a \n        pattern or practice that violates section 301(l), the State may \nbring a civil action on behalf of its residents in an appropriate \ndistrict court of the United States to enjoin such practice, to enforce \ncompliance with such section (including a nationwide injunction), to \nobtain damages, restitution, or other compensation on behalf of \nresidents of such State, to obtain reasonable attorneys' fees and costs \nif the State prevails in the civil action, or to obtain such further \nand other relief as the court may deem appropriate.\n            ``(2) Notice.--The State shall serve prior written notice \n        of any civil action under paragraph (1) or (5)(B) upon the \n        Secretary and provide the Secretary with a copy of its \n        complaint, except that if it is not feasible for the State to \n        provide such prior notice, the State shall serve such notice \n        immediately upon instituting such action. Upon receiving a \n        notice respecting a civil action, the Secretary shall have the \n        right--\n                    ``(A) to intervene in such action;\n                    ``(B) upon so intervening, to be heard on all \n                matters arising therein; and\n                    ``(C) to file petitions for appeal.\n            ``(3) Construction.--For purposes of bringing any civil \n        action under paragraph (1), nothing in this chapter shall \n        prevent an attorney general of a State from exercising the \n        powers conferred on the attorney general by the laws of such \n        State to conduct investigations or to administer oaths or \n        affirmations or to compel the attendance of witnesses or the \n        production of documentary and other evidence.\n            ``(4) Venue; service of process.--\n                    ``(A) Venue.--Any civil action brought under \n                paragraph (1) in a district court of the United States \n                may be brought in the district in which the defendant \n                is found, is an inhabitant, or transacts business or \n                wherever venue is proper under section 1391 of title \n                28, United States Code.\n                    ``(B) Service of process.--Process in such an \n                action may be served in any district in which the \n                defendant is an inhabitant or in which the defendant \n                may be found.\n            ``(5) Actions by other state officials.--\n                    ``(A) Effect of section.--Nothing contained in this \n                section shall prohibit an authorized State official \n                from proceeding in State court on the basis of an \n                alleged violation of any civil or criminal statute of \n                such State.\n                    ``(B) Additional action.--In addition to actions \n                brought by an attorney general of a State under \n                paragraph (1), such an action may be brought by \n                officers of such State who are authorized by the State \n                to bring actions in such State on behalf of its \n                residents.\n    ``(d) Interactive Computer Service; Advertising.--No provider of an \ninteractive computer service, as defined in section 230(f)(2) of the \nCommunications Act of 1934 (47 U.S.C. 230(f)(2)), or of advertising \nservices shall be liable under this section for dispensing or selling \nprescription drugs in violation of this section on account of another \nperson's selling or dispensing such drugs, provided that the provider \nof the interactive computer service or of advertising services does not \nown or exercise corporate control over such person.\n    ``(e) Definitions.--For purposes of this section:\n            ``(1) Practitioner.--The term `practitioner' means a \n        practitioner referred to in section 503(b)(1) with respect to \n        issuing a written or oral prescription.\n            ``(2) Prescription drug.--The term `prescription drug' \n        means a drug that is subject to section 503(b)(1).\n            ``(3) Qualifying medical relationship.--The term \n        `qualifying medical relationship', with respect to a \n        practitioner and a patient, has the meaning indicated for such \n        term in subsection (b).''.\n    (b) Inclusion as Prohibited Act.--Section 301 of the Federal Food, \nDrug, and Cosmetic Act (21 U.S.C. 331) is amended by inserting after \nparagraph (k) the following:\n    ``(l) The dispensing or selling of a prescription drug in violation \nof section 503B.''.\n    (c) Internet Sales of Prescription Drugs; Consideration by \nSecretary of Practices and Procedures for Certification of Legitimate \nBusinesses.--In carrying out section 503B of the Federal Food, Drug, \nand Cosmetic Act (as added by subsection (a)), the Secretary of Health \nand Human Services shall take into consideration the practices and \nprocedures of public or private entities that certify that businesses \nselling prescription drugs through Internet sites are legitimate \nbusinesses, including practices and procedures regarding disclosure \nformats and verification programs.\n    (d) Effective Date.--The amendments made by subsections (a) and (b) \ntake effect upon the expiration of the 60-day period beginning on the \ndate of enactment of this Act, without regard to whether a final rule \nto implement such amendments has been promulgated by the Secretary of \nHealth and Human Services under section 701(a) of the Federal Food, \nDrug, and Cosmetic Act (21 U.S.C. 371(a)). The preceding sentence may \nnot be construed as affecting the authority of such Secretary to \npromulgate such a final rule.\n\nSEC. 3. REPORTS REGARDING INTERNET-RELATED VIOLATIONS OF FEDERAL AND \n              STATE LAWS ON DISPENSING OF DRUGS.\n\n    (a) In General.--The Secretary of Health and Human Services \n(referred to in this section as the ``Secretary'') shall, pursuant to \nthe submission of an application meeting the criteria of the Secretary, \naward a grant or contract to the National Clearinghouse on Internet \nPrescribing (operated by the Federation of State Medical Boards) for \nthe purpose of--\n            (1) identifying Internet sites that appear to be in \n        violation of Federal or State laws concerning the dispensing of \n        drugs;\n            (2) reporting such sites to State medical licensing boards \n        and State pharmacy licensing boards, and to the Attorney \n        General and the Secretary, for further investigation; and\n            (3) submitting, for each fiscal year for which the award \n        under this subsection is made, a report to the Secretary \n        describing investigations undertaken with respect to violations \n        described in paragraph (1).\n    (b) Authorization of Appropriations.--For the purpose of carrying \nout subsection (a), there is authorized to be appropriated $100,000 for \neach of the fiscal years 2004 through 2006."
}